Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones

Go back to Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
(NYSE: RCUS) Delayed: 28.58 +0.16 (0.56%)
Previous Close $28.42    52 Week High
Open $28.67    52 Week Low
Day High $29.63    P/E N/A 
Day Low $28.52    EPS
Volume 204,440